✦ LIBER ✦

Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden

✍ Scribed by Walker, Mark S.; Masaquel, Anthony S.; Kerr, Jiandong; Lalla, Deepa; Abidoye, Oyewale; Houts, Arthur C.; Schwartzberg, Lee S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of antiresorptive therapies in

✍ Dulcinea Candelaria-Quintana; Zoneddy R. Dayao; Melanie E. Royce 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 246 KB

Low-Dose Metronomic Oral Administration

✍ Raffaele Addeo; Alessandro Sgambato; Gregorio Cennamo; Liliana Montella; Vincenz 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 683 KB

Phase II Multicenter Trial of Albumin-Bo

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

A cost-benefit analysis of bevacizumab i

✍ Alberto J. Montero; Kiran Avancha; Stefan Glück; Gilberto Lopes 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Activity and safety of vinorelbine and c

✍ R. Palumbo; A. Bernardo; M. Strada; C. Teragni; G. Poggi; M. Frascaroli; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Trial of Weekly Docetaxel, Vino

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB